Decades of underfunding mean that we still lack the tests and treatments to tackle this brutal disease. Hope alone can’t fix this. People with pancreatic cancer need action now.
That’s why our research strategy is vitally important. It aims to transform the future for people with pancreatic cancer. From cutting-edge tests to cancer-killing therapies, our scientists are striving for earlier detection and better treatment.
We’re also investing in the brightest minds, to grow the research community and accelerate the life-saving breakthroughs that we so urgently need.
Late diagnosis is one of the biggest issues in pancreatic cancer but we’re investing in ground-breaking research to change this.
As well as investing in research to save lives, we’re also working to transform people’s experience of pancreatic cancer, funding new approaches and encouraging innovative thinking.
Our strategy lays out how we will work with world leading researchers and with people affected by pancreatic cancer, to fund research that will transform and save lives.
Researchers will find the breakthroughs needed in pancreatic cancer, so we must do everything we can to build and support the community.
Find out more about opportunities for funding and support for the pancreatic cancer research community. Together we are the research community taking pancreatic cancer on.
3 July 2025
19 June 2025
Our Grand Challenge award researchers explored the best way to use immunotherapy alongside other promising new treatments for pancreatic cancer. Here ...
18 June 2025
We're proud to have worked with the NHS to develop a new case-finding pilot, which could help improve the early detection of pancreatic cancer and ena...
3 July 2025
19 June 2025
Our Grand Challenge award researchers explored the best way to use immunotherapy alongside other promising new treatments for pancreatic cancer. Here ...
18 June 2025
We're proud to have worked with the NHS to develop a new case-finding pilot, which could help improve the early detection of pancreatic cancer and ena...
